A PharmD candidate reflects on the small, evidence-backed daily habits that helped her thrive—not just survive—through pharmacy school's most demanding years.
|Articles|May 23, 2020
- May 2020
- Volume 90
- Issue 5
Pharmacy Times digital issue (May 2020)
Pharmacy Times™ digital issue (May 2020)
Advertisement
Articles in this issue
over 6 years ago
Interactives: Case Studies (May 2020)over 6 years ago
Pet Peeves (May 2020)over 6 years ago
Palforzia From Aimmune Therapeutics Incover 6 years ago
Spread the Word About Medication Therapy Management Servicesover 6 years ago
Acne Can Be Troublesome But Responds to Treatmentover 6 years ago
Drug Manufacturers Must Increase Transparency During Pandemicover 6 years ago
Generic Products (May 2020)Advertisement
Related to this article
Understanding local health care priorities is essential to developing meaningful solutions.
Phase 2 DeLLphi-309 data show comparable activity in previously treated SCLC with less frequent dosing.
The most enduring resources a preceptor can give students are the confidence and tools to ask deeper questions.
Mounjaro becomes the first GIP/GLP-1 receptor agonist cleared to lower MACE risk, based on the SURPASS-CVOT head-to-head trial.
Two recent graduates share strategies for standing out in the competitive fellowship application process.
Community pharmacies are access points, safe places, and sources of stability when everything else feels uncertain.
Impostor syndrome prevalence in oncology pharmacists is a complex topic that is not well described.
Advertisement
Advertisement
Trending on Pharmacy Times
1
CKM Syndrome Stage Linked to CKD Odds, But Primary Care Hurdles Remain
2
SGLT2 Inhibitors Benefit Frail Adults With T2D, Remain Underused
3
FDA Approves Awiqli, Once-Weekly Insulin, for Children Aged 10 Years and Older With T2D
4
Kidney Week 2026: What to Know for Nephrology's Biggest Meeting
5